Report Detail
Global Tetanus Vaccine Market Insights, Forecast to 2025
- RnM2989343 |
- 04 June, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.
The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.
A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.
The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.
The global Tetanus Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tetanus Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Tetanus Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tetanus Vaccine in these regions.
This research report categorizes the global Tetanus Vaccine market by top players/brands, region, type and end user. This report also studies the global Tetanus Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline plc
Pfizer,Inc
Merck & Co.,Inc
Sanofi Pasteur SA
Biological E
Dano Vaccine &Biological Pvt.Ltd.,
Panera
Shantha Biotechnics Ltd
Market size by Product
Diphtheria and tetanus (DT) vaccines
Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
Tetanus and diphtheria (Td) vaccines
Tetanus, diphtheria, and pertussis (Tdap) vaccines
Market size by End User
Adult
Pediatric
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Tetanus Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Tetanus Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tetanus Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Tetanus Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Tetanus Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tetanus Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Tetanus Vaccine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Tetanus Vaccine Market Size Growth Rate by Product
- 1.4.2 Diphtheria and tetanus (DT) vaccines
- 1.4.3 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
- 1.4.4 Tetanus and diphtheria (Td) vaccines
- 1.4.5 Tetanus, diphtheria, and pertussis (Tdap) vaccines
- 1.5 Market by End User
- 1.5.1 Global Tetanus Vaccine Market Size Growth Rate by End User
- 1.5.2 Adult
- 1.5.3 Pediatric
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Tetanus Vaccine Market Size
- 2.1.1 Global Tetanus Vaccine Revenue 2014-2025
- 2.1.2 Global Tetanus Vaccine Sales 2014-2025
- 2.2 Tetanus Vaccine Growth Rate by Regions
- 2.2.1 Global Tetanus Vaccine Sales by Regions
- 2.2.2 Global Tetanus Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Tetanus Vaccine Sales by Manufacturers
- 3.1.1 Tetanus Vaccine Sales by Manufacturers
- 3.1.2 Tetanus Vaccine Sales Market Share by Manufacturers
- 3.1.3 Global Tetanus Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.2 Tetanus Vaccine Revenue by Manufacturers
- 3.2.1 Tetanus Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Tetanus Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.3 Tetanus Vaccine Price by Manufacturers
- 3.4 Tetanus Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Tetanus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Tetanus Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Tetanus Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Tetanus Vaccine Sales by Product
- 4.2 Global Tetanus Vaccine Revenue by Product
- 4.3 Tetanus Vaccine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Tetanus Vaccine Breakdown Data by End User
6 North America
- 6.1 North America Tetanus Vaccine by Countries
- 6.1.1 North America Tetanus Vaccine Sales by Countries
- 6.1.2 North America Tetanus Vaccine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Tetanus Vaccine by Product
- 6.3 North America Tetanus Vaccine by End User
7 Europe
- 7.1 Europe Tetanus Vaccine by Countries
- 7.1.1 Europe Tetanus Vaccine Sales by Countries
- 7.1.2 Europe Tetanus Vaccine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Tetanus Vaccine by Product
- 7.3 Europe Tetanus Vaccine by End User
8 Asia Pacific
- 8.1 Asia Pacific Tetanus Vaccine by Countries
- 8.1.1 Asia Pacific Tetanus Vaccine Sales by Countries
- 8.1.2 Asia Pacific Tetanus Vaccine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Tetanus Vaccine by Product
- 8.3 Asia Pacific Tetanus Vaccine by End User
9 Central & South America
- 9.1 Central & South America Tetanus Vaccine by Countries
- 9.1.1 Central & South America Tetanus Vaccine Sales by Countries
- 9.1.2 Central & South America Tetanus Vaccine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Tetanus Vaccine by Product
- 9.3 Central & South America Tetanus Vaccine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Tetanus Vaccine by Countries
- 10.1.1 Middle East and Africa Tetanus Vaccine Sales by Countries
- 10.1.2 Middle East and Africa Tetanus Vaccine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Tetanus Vaccine by Product
- 10.3 Middle East and Africa Tetanus Vaccine by End User
11 Company Profiles
- 11.1 GlaxoSmithKline plc
- 11.1.1 GlaxoSmithKline plc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GlaxoSmithKline plc Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GlaxoSmithKline plc Tetanus Vaccine Products Offered
- 11.1.5 GlaxoSmithKline plc Recent Development
- 11.2 Pfizer,Inc
- 11.2.1 Pfizer,Inc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer,Inc Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer,Inc Tetanus Vaccine Products Offered
- 11.2.5 Pfizer,Inc Recent Development
- 11.3 Merck & Co.,Inc
- 11.3.1 Merck & Co.,Inc Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Merck & Co.,Inc Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Merck & Co.,Inc Tetanus Vaccine Products Offered
- 11.3.5 Merck & Co.,Inc Recent Development
- 11.4 Sanofi Pasteur SA
- 11.4.1 Sanofi Pasteur SA Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sanofi Pasteur SA Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sanofi Pasteur SA Tetanus Vaccine Products Offered
- 11.4.5 Sanofi Pasteur SA Recent Development
- 11.5 Biological E
- 11.5.1 Biological E Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Biological E Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Biological E Tetanus Vaccine Products Offered
- 11.5.5 Biological E Recent Development
- 11.6 Dano Vaccine &Biological Pvt.Ltd.,
- 11.6.1 Dano Vaccine &Biological Pvt.Ltd., Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Products Offered
- 11.6.5 Dano Vaccine &Biological Pvt.Ltd., Recent Development
- 11.7 Panera
- 11.7.1 Panera Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Panera Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Panera Tetanus Vaccine Products Offered
- 11.7.5 Panera Recent Development
- 11.8 Shantha Biotechnics Ltd
- 11.8.1 Shantha Biotechnics Ltd Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Shantha Biotechnics Ltd Tetanus Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Shantha Biotechnics Ltd Tetanus Vaccine Products Offered
- 11.8.5 Shantha Biotechnics Ltd Recent Development
12 Future Forecast
- 12.1 Tetanus Vaccine Market Forecast by Regions
- 12.1.1 Global Tetanus Vaccine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Tetanus Vaccine Revenue Forecast by Regions 2019-2025
- 12.2 Tetanus Vaccine Market Forecast by Product
- 12.2.1 Global Tetanus Vaccine Sales Forecast by Product 2019-2025
- 12.2.2 Global Tetanus Vaccine Revenue Forecast by Product 2019-2025
- 12.3 Tetanus Vaccine Market Forecast by End User
- 12.4 North America Tetanus Vaccine Forecast
- 12.5 Europe Tetanus Vaccine Forecast
- 12.6 Asia Pacific Tetanus Vaccine Forecast
- 12.7 Central & South America Tetanus Vaccine Forecast
- 12.8 Middle East and Africa Tetanus Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Tetanus Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Tetanus Vaccine . Industry analysis & Market Report on Tetanus Vaccine is a syndicated market report, published as Global Tetanus Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Tetanus Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
